Compounding BPC-157: A regulatory loophole In a statement, Health Canada said "BPC157 has not been authorized, its safety, efficacy, and quality have not been assessed and there is limited scientific evidence to support its use, including a lack of established human dosing protocols." In addition, the regulator says BPC-157 is not approved for use in any NHPs in any form, including oral and injectable, but it can still be compounded for topical use or oral administration as an NHP
This page does not describe outcomes or practical applications beyond lawful research handling
When you consult experienced specialists who use the most advanced technology and effective laser treatments, they will be able to remove your tattoos in fewer treatment sessions
Metabolic health benefits Recent research suggests that AOD-9604 may improve metabolic health, supporting overall well-being and reducing the risk of obesity-related diseases, including metabolic syndrome